Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF. 
Bloomberg News Health Care Reporter Madison Muller discusses that patients taking Eli Lilly’s blockbuster weight-loss shot were 94% less likely to develop diabetes in a three-year study that illuminates the long-term health benefits of treating obesity.
Hosts: Tim Stenovec and Katie Greifeld. Producer: Paul Brennan. 

Watch Carol and Tim LIVE every day on YouTube: <a href="http://bit.ly/3vTiACF" data-destination="rte:bind">http://bit.ly/3vTiACF</a>. Bloomberg News Health Care Reporter Madison Muller discusses that patients taking Eli Lilly’s blockbuster weight-loss shot were 94% less likely to develop diabetes in a three-year study that illuminates the long-term health benefits of treating obesity. Hosts: Tim Stenovec and Katie Greifeld. Producer: Paul Brennan.

Listen for reporting from the magazine that helps global leaders stay ahead. 

Hosts Carol Massar and Tim Stenovec bring you insight on the people, companies and trends shaping today's complex economy.  You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET: http://bit.ly/3vTiACF. 

Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar and Tim Stenovec bring you insight on the people, companies and trends shaping today's complex economy.&nbsp; You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.&nbsp;

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.

Bloomberg Businessweek

Lilly’s Zepbound Cut Risk of Diabetes by 94% in Obese People

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/0fc2301b-586e-4144-b6f9-b1d300c26c39/transcript

Featuring some of our favorite conversations of the week from our daily radio show “Bloomberg Businessweek Daily.” Hosted by Carol Massar and Tim Stenovec Hear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 92.9 FM Boston, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 121, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio. You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News. Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno and @BW

Featuring some of our favorite conversations of the week from our daily radio show &ldquo;Bloomberg Businessweek Daily.&rdquo; Hosted by Carol Massar and Tim Stenovec Hear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 92.9 FM Boston, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 121, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio. You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News. Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno and @BW

Bloomberg Businessweek Weekend: March 6th, 2026

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/c51023b5-cc9c-4fe3-a7d7-b4050181ccd7/transcript

The people, companies and trends shaping the global economy.

Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.

Oracle Corp. and OpenAI have scrapped plans to expand a flagship artificial intelligence data center in Texas after negotiations dragged over financing and OpenAI’s changing needs.

The collapsed talks created an opening for Meta Platforms Inc. to step in and consider leasing the planned expansion site in Abilene, Texas, from developer Crusoe, according to people familiar with the matter. Nvidia Corp., the leading AI chipmaker, helped facilitate Meta’s discussions with the developer, said the people, who asked not to be identified because the talks are private.

The shifting plans underscore the complexity of building out AI data centers, which are expected to cost in the tens of billions of dollars and require cooperation from a wide swath of partners.

The campus being developed by Crusoe in Abilene is part of the highly publicized Stargate project, which was announced last year at the White House with President Donald Trump. While the 1,000-acre site continues to be built, and several parts are up and running, Oracle and OpenAI elected not to go forward with tentative plans to lease a large expansion, the people said.

Oracle and OpenAI are using Nvidia’s AI semiconductors at the Stargate site. With Crusoe seeking a tenant, Nvidia became involved to ensure its products would still fill the expanded data center rather than that of rival Advanced Micro Devices Inc., said the people. Nvidia paid a $150 million deposit to Crusoe and began helping court Meta as a tenant for the expansion, the people said.
Today's show features:
Ed Ludlow, Bloomberg Tech co-host on Oracle and OpenAI End Plans to Expand Flagship Data Center
Ellen Wald, President of Transversal Consulting and Senior Fellow at the Atlantic Council, on oil markets
James Crombie, Bloomberg News Senior Editor on Credit, on how broad credit markers are reacting to war and inflation
Drive to the Close with Sevasti Balafas, CEO at GoalVest Advisory

The people, companies and trends shaping the global economy.
Watch Carol and Tim LIVE every day on YouTube:&nbsp;<a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.
Oracle Corp. and OpenAI have scrapped plans to expand a flagship artificial intelligence data center in Texas after negotiations dragged over financing and OpenAI&rsquo;s changing needs.
The collapsed talks created an opening for Meta Platforms Inc. to step in and consider leasing the planned expansion site in Abilene, Texas, from developer Crusoe, according to people familiar with the matter. Nvidia Corp., the leading AI chipmaker, helped facilitate Meta&rsquo;s discussions with the developer, said the people, who asked not to be identified because the talks are private.
The shifting plans underscore the complexity of building out AI data centers, which are expected to cost in the tens of billions of dollars and require cooperation from a wide swath of partners.
The campus being developed by Crusoe in Abilene is part of the highly publicized Stargate project, which was announced last year at the White House with President Donald Trump. While the 1,000-acre site continues to be built, and several parts are up and running, Oracle and OpenAI elected not to go forward with tentative plans to lease a large expansion, the people said.
Oracle and OpenAI are using Nvidia&rsquo;s AI semiconductors at the Stargate site. With Crusoe seeking a tenant, Nvidia became involved to ensure its products would still fill the expanded data center rather than that of rival Advanced Micro Devices Inc., said the people. Nvidia paid a $150 million deposit to Crusoe and began helping court Meta as a tenant for the expansion, the people said. Today's show features:
<ul>
<li>Ed Ludlow, Bloomberg Tech co-host on Oracle and OpenAI End Plans to Expand Flagship Data Center</li>
<li>Ellen Wald, President of Transversal Consulting and Senior Fellow at the Atlantic Council, on oil markets</li>
<li>James Crombie, Bloomberg News Senior Editor on Credit, on how broad credit markers are reacting to war and inflation</li>
<li>Drive to the Close with Sevasti Balafas, CEO at GoalVest Advisory</li>
</ul>

Oracle and OpenAI End Plans to Expand Flagship Data Center

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/fa4b212b-3ebc-4184-bc06-b4050178b530/transcript

Carlsmed is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. They are focused on becoming the standard of care for spine fusion surgery. They've been using technology and AI-enabled 3D surgical planning and implants personalized for each patient.

Mike Cordonnier is the co-founder and serves as Chief Executive Officer and President of Carlsmed, he also serves as Chairman of the Board of Directors. He speaks with Carol Massar and Tim Stenovec on the company's earnings and commercial & growth strategy.

Carlsmed is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. They are focused on becoming the standard of care for spine fusion surgery. They've been using technology and AI-enabled 3D surgical planning and implants personalized for each patient.
Mike Cordonnier is the co-founder and serves as Chief Executive Officer and President of Carlsmed, he also serves as Chairman of the Board of Directors. He speaks with Carol Massar and Tim Stenovec on the company's earnings and commercial &amp; growth strategy.

Carlsmed CEO on Cutting-Edge Spinal Care Technology  

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/b87da615-108a-4c2f-9505-b4050172079c/transcript

Lilly’s Zepbound Cut Risk of Diabetes by 94% in Obese People

In 1 playlist(s)

Bloomberg Businessweek

Social links

Follow podcast

Recent clips